查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1624345

梅毒免疫分析診斷市場；技術：- 2024-2034 年全球產業分析、規模、佔有率、成長、趨勢與預測

Syphilis Immunoassay Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 241 Pages | 商品交期: 2-10個工作天內

價格

梅毒免疫分析診斷市場 - 報告範圍

TMR 關於全球梅毒免疫分析診斷市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。 2034年期間的市場，考慮2024年為基準年，2034年為預測年。該報告也提供了2024年至2034年全球梅毒免疫分析診斷市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解梅毒免疫分析診斷市場。

市場概況
2023年市場價值 5.485 億美元
2034 年市場價值 9.785 億美元
複合年成長率 5.5%

該報告深入探討了全球梅毒免疫分析診斷市場的競爭格局。全球梅毒免疫分析診斷市場的主要參與者已被確定，並且每位參與者都已根據各種屬性進行了分析。公司概述、財務狀況、最新發展和 SWOT 是本報告中介紹的全球梅毒免疫分析診斷市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034 年全球市場分析與預測
  • 波特五力分析

第 5 章：關鍵見解

  • 重要行業活動
  • 經銷商版圖
  • 波特的五力分析
  • 最終用戶偏好
  • 按地區/國家分類的梅毒流行病學
  • 各地區/國家的政府舉措
  • 按地區/國家分類的醫療保健支出（醫療支出總額，美元/人，2022 年）
  • PESTEL分析
  • 近距離病患檢測與 POC 對梅毒市場動態的影響
  • 品牌和定價分析
  • 按地區/國家分類的監管場景
  • 供應鏈分析
  • 技術進步

第 6 章：全球市場分析與預測：依產品分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年各產品市場價值預測
    • 分析儀
    • 試劑盒和試劑
  • 按產品分類的市場吸引力

第 7 章：全球市場分析與預測：依技術分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年技術市場價值預測
    • 化學發光分析 (CLIA)
    • 酵素連結免疫吸附測定法 (ELISA
    • 免疫層析法/側流層析法
    • 梅毒螺旋體乳膠凝集（TPLA）
    • 非密螺旋體絮凝試驗
  • 技術的市場吸引力

第 8 章：全球市場分析與預測：按測試類型

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按測試類型分類的市場價值預測
    • 密螺旋體測試
    • 非密螺旋體測試
  • 按測試類型分類的市場吸引力

第 9 章：全球市場分析與預測：按測試地點

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按測試地點分類的市場價值預測
    • 即時檢測 (POCT)
    • 患者自檢 (PST)
    • 臨床環境
  • 按測試地點分類的市場吸引力

第 10 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年最終用戶市場價值預測
    • 醫院和診所
    • 診斷實驗室
    • 居家護理
    • 公共衛生實驗室
    • 其他
  • 最終用戶的市場吸引力

第 11 章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 12 章：北美市場分析與預測

  • 美國
  • 加拿大

第 13 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 14 章：亞太市場分析與預測

  • 中國
  • 日本
  • 印度
  • 澳洲和紐西蘭
  • 亞太地區其他地區

第 15 章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 16 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第17章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2023）
  • 公司簡介
    • Abbott
    • Becton, Dickinson, and Company (BD)
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc
    • Chembio Diagnostics, Inc.
    • Danaher Corporation
    • DiaSorin SpA
    • Roche Diagnostics (F. Hoffmann-La Roche AG)
    • Fujirebio
    • QuidelOrtho Corporation
    • Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • Siemens Healthineers AG
    • Sekisui Chemical Co Ltd
    • Thermo Fisher Scientific, Inc.
    • Trinity Biotech
Product Code: TMRGL2140

Syphilis Immunoassay Diagnostics Market - Scope of Report

TMR's report on the global syphilis immunoassay diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global syphilis immunoassay diagnostics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global syphilis immunoassay diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the syphilis immunoassay diagnostics market.

Market Snapshot
Market Value in 2023US$ 548.5 Mn
Market Value in 2034US$ 978.5 Mn
CAGR5.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global syphilis immunoassay diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global syphilis immunoassay diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global syphilis immunoassay diagnostics market.

The report delves into the competitive landscape of the global syphilis immunoassay diagnostics market. Key players operating in the global syphilis immunoassay diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global syphilis immunoassay diagnostics market profiled in this report.

Key Questions Answered in Global syphilis immunoassay diagnostics Market Report:

  • What is the sales/revenue generated by syphilis immunoassay diagnostics across all regions during the forecast period?
  • What are the opportunities in the global syphilis immunoassay diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Syphilis Immunoassay Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global syphilis immunoassay diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global syphilis immunoassay diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global syphilis immunoassay diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Syphilis Immunoassay Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)
    • 4.4.2. Market Volume/Unit Shipments Projections
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Distributors Landscape
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. End-user Preference
  • 5.5. Epidemiology of Syphilis by Region/Countries
  • 5.6. Government Initiatives by Region/Countries
  • 5.7. Healthcare Expenditure by Region/Country (Health spending Total, US dollars/capita, 2022)
  • 5.8. PESTEL Analysis
  • 5.9. Impact of near patient testing and POC on syphilis market dynamics
  • 5.10. Brand and Pricing Analysis
  • 5.11. Regulatory Scenario by Region/ Country
  • 5.12. Supply Chain Analysis
  • 5.13. Technological Advancements

6. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product, 2020-2034
    • 6.3.1. Analyzer
    • 6.3.2. Kits & Reagents
  • 6.4. Market Attractiveness By Product

7. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Technology, 2020-2034
    • 7.3.1. Chemiluminescence Assay (CLIA)
    • 7.3.2. Enzyme Linked Immunosorbent Assay (ELISA
    • 7.3.3. Immunochromatographic Assay /Lateral Flow Assay
    • 7.3.4. Treponema pallidum latex agglutination (TPLA)
    • 7.3.5. Non-treponemal Flocculation Assay
  • 7.4. Market Attractiveness By Technology

8. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Test Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Test Type, 2020-2034
    • 8.3.1. Treponemal Tests
    • 8.3.2. Non-Treponemal Tests
  • 8.4. Market Attractiveness By Test Type

9. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Location of Testing

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Location of Testing, 2020-2034
    • 9.3.1. Point-of-care testing (POCT)
    • 9.3.2. Patient Self-Tests (PST)
    • 9.3.3. Clinical Settings
  • 9.4. Market Attractiveness By Location of Testing

10. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By End-user, 2020-2034
    • 10.3.1. Hospitals and Clinics
    • 10.3.2. Diagnostics Laboratories
    • 10.3.3. Home Care
    • 10.3.4. Public Health Laboratory
    • 10.3.5. Others
  • 10.4. Market Attractiveness By End-user

11. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast By Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness By Country/Region

12. North America Syphilis Immunoassay Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product, 2020-2034
    • 12.2.1. Analyzer
    • 12.2.2. Kits & Reagents
  • 12.3. Market Value Forecast By Technology, 2020-2034
    • 12.3.1. Chemiluminescence Assay (CLIA)
    • 12.3.2. Enzyme Linked Immunosorbent Assay (ELISA
    • 12.3.3. Immunochromatographic Assay /Lateral Flow Assay
    • 12.3.4. Treponema pallidum latex agglutination (TPLA)
    • 12.3.5. Non-treponemal Flocculation Assay
  • 12.4. Market Value Forecast By Test Type, 2020-2034
    • 12.4.1. Treponemal Tests
    • 12.4.2. Non-Treponemal Tests
  • 12.5. Market Value Forecast By Location of Testing, 2020-2034
    • 12.5.1. Point-of-care testing (POCT)
    • 12.5.2. Patient Self-Tests (PST)
    • 12.5.3. Clinical Settings
  • 12.6. Market Value Forecast By End-user, 2020-2034
    • 12.6.1. Hospitals and Clinics
    • 12.6.2. Diagnostics Laboratories
    • 12.6.3. Home Care
    • 12.6.4. Public Health Laboratory
    • 12.6.5. Others
  • 12.7. Market Value Forecast By Country, 2020-2034
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Product
    • 12.8.2. By Technology
    • 12.8.3. By Test Type
    • 12.8.4. By Location of Testing
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Syphilis Immunoassay Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product, 2020-2034
    • 13.2.1. Analyzer
    • 13.2.2. Kits & Reagents
  • 13.3. Market Value Forecast By Technology, 2020-2034
    • 13.3.1. Chemiluminescence Assay (CLIA)
    • 13.3.2. Enzyme Linked Immunosorbent Assay (ELISA
    • 13.3.3. Immunochromatographic Assay /Lateral Flow Assay
    • 13.3.4. Treponema pallidum latex agglutination (TPLA)
    • 13.3.5. Non-treponemal Flocculation Assay
  • 13.4. Market Value Forecast By Test Type, 2020-2034
    • 13.4.1. Treponemal Tests
    • 13.4.2. Non-Treponemal Tests
  • 13.5. Market Value Forecast By Location of Testing, 2020-2034
    • 13.5.1. Point-of-care testing (POCT)
    • 13.5.2. Patient Self-Tests (PST)
    • 13.5.3. Clinical Settings
  • 13.6. Market Value Forecast By End-user, 2020-2034
    • 13.6.1. Hospitals and Clinics
    • 13.6.2. Diagnostics Laboratories
    • 13.6.3. Home Care
    • 13.6.4. Public Health Laboratory
    • 13.6.5. Others
  • 13.7. Market Value Forecast By Country, 2020-2034
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Product
    • 13.8.2. By Technology
    • 13.8.3. By Test Type
    • 13.8.4. By Location of Testing
    • 13.8.5. By End-user
    • 13.8.6. By Country

14. Asia Pacific Syphilis Immunoassay Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product, 2020-2034
    • 14.2.1. Analyzer
    • 14.2.2. Kits & Reagents
  • 14.3. Market Value Forecast By Technology, 2020-2034
    • 14.3.1. Chemiluminescence Assay (CLIA)
    • 14.3.2. Enzyme Linked Immunosorbent Assay (ELISA
    • 14.3.3. Immunochromatographic Assay /Lateral Flow Assay
    • 14.3.4. Treponema pallidum latex agglutination (TPLA)
    • 14.3.5. Non-treponemal Flocculation Assay
  • 14.4. Market Value Forecast By Test Type, 2020-2034
    • 14.4.1. Treponemal Tests
    • 14.4.2. Non-Treponemal Tests
  • 14.5. Market Value Forecast By Location of Testing, 2020-2034
    • 14.5.1. Point-of-care testing (POCT)
    • 14.5.2. Patient Self-Tests (PST)
    • 14.5.3. Clinical Settings
  • 14.6. Market Value Forecast By End-user, 2020-2034
    • 14.6.1. Hospitals and Clinics
    • 14.6.2. Diagnostics Laboratories
    • 14.6.3. Home Care
    • 14.6.4. Public Health Laboratory
    • 14.6.5. Others
  • 14.7. Market Value Forecast By Country, 2020-2034
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Product
    • 14.8.2. By Technology
    • 14.8.3. By Test Type
    • 14.8.4. By Location of Testing
    • 14.8.5. By End-user
    • 14.8.6. By Country

15. Latin America Syphilis Immunoassay Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product, 2020-2034
    • 15.2.1. Analyzer
    • 15.2.2. Kits & Reagents
  • 15.3. Market Value Forecast By Technology, 2020-2034
    • 15.3.1. Chemiluminescence Assay (CLIA)
    • 15.3.2. Enzyme Linked Immunosorbent Assay (ELISA
    • 15.3.3. Immunochromatographic Assay /Lateral Flow Assay
    • 15.3.4. Treponema pallidum latex agglutination (TPLA)
    • 15.3.5. Non-treponemal Flocculation Assay
  • 15.4. Market Value Forecast By Test Type, 2020-2034
    • 15.4.1. Treponemal Tests
    • 15.4.2. Non-Treponemal Tests
  • 15.5. Market Value Forecast By Location of Testing, 2020-2034
    • 15.5.1. Point-of-care testing (POCT)
    • 15.5.2. Patient Self-Tests (PST)
    • 15.5.3. Clinical Settings
  • 15.6. Market Value Forecast By End-user, 2020-2034
    • 15.6.1. Hospitals and Clinics
    • 15.6.2. Diagnostics Laboratories
    • 15.6.3. Home Care
    • 15.6.4. Public Health Laboratory
    • 15.6.5. Others
  • 15.7. Market Value Forecast By Country, 2020-2034
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Product
    • 15.8.2. By Technology
    • 15.8.3. By Test Type
    • 15.8.4. By Location of Testing
    • 15.8.5. By End-user
    • 15.8.6. By Country

16. Middle East & Africa Syphilis Immunoassay Diagnostics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Product, 2020-2034
    • 16.2.1. Analyzer
    • 16.2.2. Kits & Reagents
  • 16.3. Market Value Forecast By Technology, 2020-2034
    • 16.3.1. Chemiluminescence Assay (CLIA)
    • 16.3.2. Enzyme Linked Immunosorbent Assay (ELISA
    • 16.3.3. Immunochromatographic Assay /Lateral Flow Assay
    • 16.3.4. Treponema pallidum latex agglutination (TPLA)
    • 16.3.5. Non-treponemal Flocculation Assay
  • 16.4. Market Value Forecast By Test Type, 2020-2034
    • 16.4.1. Treponemal Tests
    • 16.4.2. Non-Treponemal Tests
  • 16.5. Market Value Forecast By Location of Testing, 2020-2034
    • 16.5.1. Point-of-care testing (POCT)
    • 16.5.2. Patient Self-Tests (PST)
    • 16.5.3. Clinical Settings
  • 16.6. Market Value Forecast By End-user, 2020-2034
    • 16.6.1. Hospitals and Clinics
    • 16.6.2. Diagnostics Laboratories
    • 16.6.3. Home Care
    • 16.6.4. Public Health Laboratory
    • 16.6.5. Others
  • 16.7. Market Value Forecast By Country, 2020-2034
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Product
    • 16.8.2. By Technology
    • 16.8.3. By Test Type
    • 16.8.4. By Location of Testing
    • 16.8.5. By End-user
    • 16.8.6. By Country

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis, by Company (2023)
  • 17.3. Company Profiles
    • 17.3.1. Abbott
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Becton, Dickinson, and Company (BD)
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. bioMerieux SA
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Bio-Rad Laboratories, Inc
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. Chembio Diagnostics, Inc.
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Danaher Corporation
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. DiaSorin S.p.A.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. Roche Diagnostics (F. Hoffmann-La Roche AG)
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Fujirebio
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. QuidelOrtho Corporation
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. Shenzhen New Industries Biomedical Engineering Co., Ltd.
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments
    • 17.3.12. Siemens Healthineers AG
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Financial Overview
      • 17.3.12.3. Product Portfolio
      • 17.3.12.4. Business Strategies
      • 17.3.12.5. Recent Developments
    • 17.3.13. Sekisui Chemical Co Ltd
      • 17.3.13.1. Company Overview
      • 17.3.13.2. Financial Overview
      • 17.3.13.3. Product Portfolio
      • 17.3.13.4. Business Strategies
      • 17.3.13.5. Recent Developments
    • 17.3.14. Thermo Fisher Scientific, Inc.
      • 17.3.14.1. Company Overview
      • 17.3.14.2. Financial Overview
      • 17.3.14.3. Product Portfolio
      • 17.3.14.4. Business Strategies
      • 17.3.14.5. Recent Developments
    • 17.3.15. Trinity Biotech
      • 17.3.15.1. Company Overview
      • 17.3.15.2. Financial Overview
      • 17.3.15.3. Product Portfolio
      • 17.3.15.4. Business Strategies
      • 17.3.15.5. Recent Developments

Syphilis Immunoassay Diagnostics Market

Syphilis Immunoassay Diagnostics Industry

Syphilis Immunoassay Diagnostics Market Size

Syphilis Immunoassay Diagnostics Market Share

Syphilis Immunoassay Diagnostics Market Growth

Syphilis Immunoassay Diagnostics Market Analysis

Syphilis Immunoassay Diagnostics Market Demand

Syphilis Immunoassay Diagnostics Market Forecast

Syphilis Immunoassay Diagnostics Market Trends

List of Tables

  • Table 01: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
  • Table 02: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Technology, 2020-2034
  • Table 03: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
  • Table 04: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Location of Testing, 2020-2034
  • Table 05: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By End-user , 2020-2034
  • Table 06: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 07: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 08: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
  • Table 09: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 10: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
  • Table 11: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034
  • Table 12: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 13: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
  • Table 15: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 16: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
  • Table 17: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034
  • Table 18: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 19: Asia Pacific Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 20: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
  • Table 21: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 22: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
  • Table 23: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034
  • Table 24: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 25: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 26: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
  • Table 27: Middle East & Africa- Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 28: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 29: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
  • Table 20: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034
  • Table 31: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 32: Middle East & Africa - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 33: Middle East & Africa - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
  • Table 34: Middle East & Africa - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 35: Middle East & Africa - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
  • Table 36: Middle East & Africa- Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034

List of Figures

  • Figure 01: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Syphilis Immunoassay Diagnostics Market Value Share, By Product, 2023
  • Figure 03: Global Syphilis Immunoassay Diagnostics Market Value Share, by Technology, 2023
  • Figure 04: Global Syphilis Immunoassay Diagnostics Market Value Share, By Test Type, 2023
  • Figure 05: Global Syphilis Immunoassay Diagnostics Market Value Share, By Location of Testing, 2023
  • Figure 06: Global Syphilis Immunoassay Diagnostics Market Value Share, by End-user, 2023
  • Figure 07: Global Syphilis Immunoassay Diagnostics Market Value Share, By Region, 2023
  • Figure 08: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Product, 2023 and 2034
  • Figure 09: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Product, 2023
  • Figure 10: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Product, 2034
  • Figure 11: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Product, 2024-2034
  • Figure 12: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Analyzer, 2020-2034
  • Figure 13: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Analyzer, 2023 and 2034
  • Figure 14: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Kits & Reagents, 2020-2034
  • Figure 15: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Finger-Based Devices, 2023 and 2034
  • Figure 16: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Technology, 2023 and 2034
  • Figure 17: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Technology, 2023
  • Figure 18: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Technology, 2034
  • Figure 19: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Technology, 2024-2034
  • Figure 20: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Chemiluminescence Assay (CLIA), 2020-2034
  • Figure 21: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Chemiluminescence Assay (CLIA), 2023 and 2034
  • Figure 22: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Enzyme Linked Immunosorbent Assay (ELISA), 2020-2034
  • Figure 23: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Enzyme Linked Immunosorbent Assay (ELISA), 2023 and 2034
  • Figure 24: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Immunochromatographic Assay /Lateral Flow Assay, 2020-2034
  • Figure 25: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Immunochromatographic Assay /Lateral Flow Assay, 2023 and 2034
  • Figure 26: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Treponema pallidum latex agglutination (TPLA), 2020-2034
  • Figure 27: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Treponema pallidum latex agglutination (TPLA), 2023 and 2034
  • Figure 28: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Non-treponemal Flocculation Assay, 2020-2034
  • Figure 29: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Non-treponemal Flocculation Assay, 2023 and 2034
  • Figure 30: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Test Type, 2023 and 2034
  • Figure 31: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Test Type, 2023
  • Figure 32: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Test Type, 2034
  • Figure 33: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Test Type, 2024-2034
  • Figure 34: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Treponemal Tests, 2020-2034
  • Figure 35: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Treponemal Tests, 2023 and 2034
  • Figure 36: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Non-Treponemal Tests, 2020-2034
  • Figure 37: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Non-Treponemal Tests, 2023 and 2034
  • Figure 38: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Location of Testing, 2023 and 2034
  • Figure 39: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Location of Testing, 2023
  • Figure 40: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Location of Testing, 2034
  • Figure 41: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Location of Testing, 2024-2034
  • Figure 42: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Point-of-care testing (POCT), 2020-2034
  • Figure 43: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Point-of-care testing (POCT), 2023 and 2034
  • Figure 44: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Patient Self-Tests (PST), 2020-2034
  • Figure 45: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Patient Self-Tests (PST), 2023 and 2034
  • Figure 46: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Clinical Settings, 2020-2034
  • Figure 47: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Clinical Settings, 2023 and 2034
  • Figure 48: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By End-user, 2023 and 2034
  • Figure 49: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By End-user, 2023
  • Figure 50: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By End-user, 2034
  • Figure 51: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By End-user , 2024-2034
  • Figure 52: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Hospitals and Clinics, 2020-2034
  • Figure 53: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Hospitals and Clinics, 2023 and 2034
  • Figure 54: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Diagnostics Laboratories, 2020-2034
  • Figure 55: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Diagnostics Laboratories, 2023 and 2034
  • Figure 56: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Home Care, 2020-2034
  • Figure 57: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Home Care, 2023 and 2034
  • Figure 58: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Public Health Laboratory, 2020-2034
  • Figure 59: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Public Health Laboratory, 2023 and 2034
  • Figure 60: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Others, 2020-2034
  • Figure 61: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 62: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 63: Global Syphilis Immunoassay Diagnostics Market Share Analysis, by Region, 2023
  • Figure 64: Global Syphilis Immunoassay Diagnostics Market Share Analysis, by Region, 2034
  • Figure 65: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 66: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 67: North America - Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 68: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 69: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Product, 2023 and 2034
  • Figure 70: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Product, 2024-2034
  • Figure 71: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 72: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 73: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Test Type, 2023 and 2034
  • Figure 74: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Test Type, 2024-2034
  • Figure 75: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, by Location of Testing, 2023 and 2034
  • Figure 76: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, by Location of Testing, 2024-2034